基因改造双歧杆菌的短链脂肪酸代谢途径优化研究
Research on the Optimization of Short-Chain Fatty Acid Metabolic Pathway in Genetically Modified Bifidobacteria
摘要: 双歧杆菌可利用膳食纤维发酵产生短链脂肪酸(SCFA)而有益于人体肠道微生物群以及代谢健康。由于天然菌株产生的SCFA量较少,在本研究中利用CRISPR-Cas9和重组质粒的方法对关键代谢酶基因进行编辑,从而改善乙酸、丙酸、丁酸合成过程。通过发酵培养与气相色谱检测,结合代谢通量分析(MFA)与酶活性测定,结果显示改造菌株产生的总SCFA量比野生型增加约45%~60%,其中乙酸含量最高。这为提高益生元活性以及开发功能性食品奠定了基础。
Abstract: Bifidobacteria can utilize dietary fiber for fermentation to produce Short-Chain Fatty Acids (SCFA), which are beneficial to human intestinal microbiota and metabolic health. Due to the low production of SCFA by natural strains, in this study, CRISPR-Cas9 and recombinant plasmid methods were utilized to edit key metabolic enzyme genes, thereby improving the synthesis processes of acetic acid, propionic acid, and butyric acid. Through fermentation culture and gas chromatography detection, combined with Metabolic Flux Analysis (MFA) and enzyme activity assay, the results showed that the total SCFA production of the modified strain increased by approximately 45% - 60% compared to the wild-type strain, with acetic acid being the most abundant. This lays the foundation for enhancing the activity of prebiotics and developing functional foods.
文章引用:肖童. 基因改造双歧杆菌的短链脂肪酸代谢途径优化研究[J]. 生物医学, 2026, 16(3): 434-441. https://doi.org/10.12677/hjbm.2026.163046

参考文献

[1] 韩啸. 基于内源I-C型CRISPR-Cas系统的短双歧杆菌基因编辑工具构建及应用[D]: [博士学位论文]. 无锡: 江南大学, 2024.
[2] 梅永超. 双歧杆菌源生物转化共轭亚油酸的关键酶BBI-like及其调控机制研究[D]: [博士学位论文]. 无锡: 江南大学, 2024.
[3] 段海亭. 青春双歧杆菌和副干酪乳酪杆菌原生质体融合子的选育及特性研究[D]: [硕士学位论文]. 呼和浩特: 内蒙古农业大学, 2024.
[4] 王楷若. 构建长双歧杆菌为载体的长效制剂治疗溃疡性结肠炎的机制研究[D]: [博士学位论文]. 上海: 同济大学, 2023.
[5] 许婷婷. 长双歧杆菌W13基因组分析及基因工程应用初步探究[D]: [硕士学位论文]. 天津: 天津科技大学, 2023.
[6] 梅璐, 赵业, 郭义联, 等. 长双歧杆菌婴儿亚种调节肠道菌群及短链脂肪酸代谢改善小鼠溃疡性结肠炎[J]. 中国微生态学杂志, 2025, 37(8): 896-905.
[7] Liu, H., Liu, G., Zhang, Y., Suo, W., Hao, Y., Wang, Y., et al. (2025) Bifidobacterium adolescentis DM8504 Alleviates Autistic-Like Behaviors in Valproic Acid-Exposed Rats through Gut Microbiota Modulation and SCFA Restoration. Neuropsychiatric Disease and Treatment, 21, 2449-2463. [Google Scholar] [CrossRef
[8] Baba, Y., Tsuge, D. and Aoki, R. (2025) Enhancement of Carbohydrate Metabolism by Probiotic and Prebiotic Intake Promotes Short-Chain Fatty Acid Production in the Gut Microbiome: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial. Bioscience, Biotechnology, and Biochemistry, 89, 1191-1202. [Google Scholar] [CrossRef] [PubMed]
[9] Huang, Y., Tang, N., Xue, Y., Li, J., Liu, W., Zhu, S., et al. (2024) Bifidobacterium bifidum CCFM1163 Alleviates Cathartic Colon through the Acetate/Propionate‐GPR41‐Gβγ Pathway. Food Frontiers, 6, 852-871. [Google Scholar] [CrossRef
[10] Paul, M., Mohapatra, S., Kumar Das Mohapatra, P. and Thatoi, H. (2021) Microbial Cellulases—An Update towards Its Surface Chemistry, Genetic Engineering and Recovery for Its Biotechnological Potential. Bioresource Technology, 340, Article ID: 125710. [Google Scholar] [CrossRef] [PubMed]
[11] Shi, S., Wang, Y., Han, Z., Wang, X., Li, P. and Shang, N. (2026) In Vitro Digestion Stability of a Bifidobacterium-Derived Extracellular Polysaccharides and Its Prebiotic Potential in Gut Microbiota Modulation. Food Chemistry, 504, Article ID: 147822. [Google Scholar] [CrossRef
[12] Vu-Le, K., Phirom-on, K., Sripattanakul, S., Chu, D.B., Hann, S., Blaukopf, M., et al. (2025) A GH42 β-Galactosidase from the Human Isolate Bifidobacterium breve DSM 20213: Biochemical and Transgalactosylation Properties Reveal the Potential for Galacto-Oligosaccharides Synthesis. ACS Omega, 10, 62633-62644. [Google Scholar] [CrossRef
[13] Shen, S., Lu, L., Tu, H., Jiang, S., Zhang, Z., Han, Z., et al. (2026) Calenduloside E Produced by Bifidobacterium animalis B960 Increases Glibenclamide Efficacy and Alleviates Drug-Induced Adverse Effects in a Type 2 Diabetes Model. Science Bulletin, 71, 520-524. [Google Scholar] [CrossRef
[14] 王一, 黄立铭, 喻喜华, 等. 青春双歧杆菌FHNFQ5M4对小鼠肠道菌群的调控及缓解小鼠结肠炎研究[J]. 食品与生物技术学报, 2025, 44(8): 49-60.